HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Buonerba Selected Research

Biomarkers (Surrogate Marker)

10/2021Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide.
3/2021Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer.
1/2019Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer.
3/2017Serum and tissue markers in colorectal cancer: State of art.
2/2016Biomarkers in localized prostate cancer.
1/2013Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.
8/2012Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
5/2011Immunotherapy for the treatment of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo Buonerba Research Topics

Disease

47Prostatic Neoplasms (Prostate Cancer)
03/2022 - 05/2010
32Neoplasms (Cancer)
02/2024 - 05/2011
15Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 07/2010
13Urinary Bladder Neoplasms (Bladder Cancer)
02/2024 - 02/2012
10Carcinoma (Carcinomatosis)
10/2023 - 03/2013
8COVID-19
01/2022 - 01/2020
7Neoplasm Metastasis (Metastasis)
09/2021 - 02/2013
6Penile Neoplasms (Penile Cancer)
02/2024 - 12/2011
6Kidney Neoplasms (Kidney Cancer)
01/2019 - 01/2011
5Non-Muscle Invasive Bladder Neoplasms
02/2024 - 02/2012
5Disease Progression
12/2021 - 01/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2023 - 12/2012
3Infections
01/2022 - 01/2021
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2019 - 02/2010
3Fatigue
06/2019 - 02/2016
3Glioblastoma (Glioblastoma Multiforme)
07/2018 - 11/2010
2Circulating Neoplastic Cells
10/2021 - 10/2016
2Pain (Aches)
09/2021 - 02/2015
2Obesity
01/2021 - 02/2017
2Margins of Excision
03/2017 - 01/2015
2Neutropenia
01/2016 - 01/2013
2Febrile Neutropenia
01/2016 - 01/2013
2Thymoma (Thymic Carcinoma)
01/2015 - 02/2012
2Nasopharyngeal Carcinoma
07/2014 - 05/2013
1Cardiotoxicity
08/2023
1Pneumonia (Pneumonitis)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1Fever (Fevers)
09/2021
1Thrombosis (Thrombus)
09/2021
1Sarcoma (Soft Tissue Sarcoma)
05/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021

Drug/Important Bio-Agent (IBA)

18Docetaxel (Taxotere)FDA Link
01/2021 - 02/2010
8Biomarkers (Surrogate Marker)IBA
10/2021 - 05/2011
8Sunitinib (Sutent)FDA Link
10/2020 - 12/2010
8cabazitaxelFDA Link
01/2017 - 07/2012
6AndrogensIBA
03/2022 - 02/2015
6Cisplatin (Platino)FDA LinkGeneric
10/2021 - 06/2011
5Immune Checkpoint InhibitorsIBA
10/2023 - 10/2020
5AntigensIBA
04/2021 - 05/2011
5taxaneIBA
06/2020 - 07/2012
5abirateroneIBA
12/2018 - 07/2012
5EverolimusFDA Link
08/2013 - 12/2010
4Androgen Receptors (Androgen Receptor)IBA
10/2021 - 10/2016
4enzalutamideIBA
10/2021 - 10/2016
4Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 05/2010
3AlbuminsIBA
02/2024 - 04/2016
3Hormones (Hormone)IBA
01/2022 - 01/2016
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2021 - 04/2018
3GemcitabineFDA Link
01/2021 - 02/2012
3Prednisone (Sone)FDA LinkGeneric
01/2017 - 06/2011
3MTOR InhibitorsIBA
11/2016 - 12/2010
3sipuleucel-T (APC8015)FDA Link
07/2012 - 01/2011
3Sorafenib (BAY 43-9006)FDA Link
07/2011 - 12/2010
2Monoclonal AntibodiesIBA
12/2023 - 11/2016
2cemiplimabIBA
12/2023 - 01/2023
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2023 - 11/2016
2fisetinIBA
03/2022 - 10/2021
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 11/2017
2AntibodiesIBA
01/2021 - 01/2021
2fotemustine (Muphoran)IBA
07/2018 - 11/2010
2Hemoglobins (Hemoglobin)IBA
04/2016 - 01/2016
2Paclitaxel (Taxol)FDA LinkGeneric
02/2016 - 12/2011
2InterferonsIBA
04/2015 - 07/2010
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2012 - 04/2010
2Bevacizumab (Avastin)FDA Link
04/2011 - 07/2010
1Alkaline PhosphataseIBA
02/2024
1Indicators and Reagents (Reagents)IBA
01/2024
1Programmed Cell Death 1 ReceptorIBA
12/2023
1Angiogenesis InhibitorsIBA
08/2023
1quercitrinIBA
07/2023
1Prothrombin (Factor II)IBA
01/2022
1darolutamideIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1VaccinesIBA
01/2022
1LectinsIBA
01/2022
1myricetinIBA
10/2021
1FlavonolsIBA
10/2021
1kaempferolIBA
10/2021
1FlavonoidsIBA
10/2021
1Heparin (Liquaemin)FDA LinkGeneric
09/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2021
1fluorocholineIBA
09/2021
1Radium-223IBA
09/2021
1S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
05/2021
1Immunoglobulin G (IgG)IBA
01/2021

Therapy/Procedure

38Therapeutics
12/2023 - 12/2010
26Castration
10/2021 - 05/2010
21Drug Therapy (Chemotherapy)
10/2023 - 02/2010
7Immunotherapy
02/2024 - 01/2011
7Radiotherapy
01/2019 - 10/2011
6Prostatectomy (Retropubic Prostatectomy)
01/2022 - 09/2011
5Cystectomy
10/2021 - 02/2012
4Neoadjuvant Therapy
10/2022 - 01/2021
3Salvage Therapy
04/2016 - 04/2015
2Lymph Node Excision (Lymph Node Dissection)
02/2024 - 10/2021
2Mediterranean Diet
10/2022 - 01/2021
1Intravesical Administration
01/2024
1Nephroureterectomy
10/2022
1Transurethral Resection of Bladder
12/2021
1Precision Medicine
03/2021